Improved survival in multiple myeloma following prior detection of precursor conditions: a nationwide real-world study
Prior detection of precursor conditions (MGUS or SMM) is associated with improved overall survival in multiple myeloma patients compared to those diagnosed de novo.
Improved survival with earlier detection supports targeted surveillance of high‑risk individuals and could influence screening and monitoring guidelines for precursor plasma‑cell disorders.
Evidence level: Korai humán adat. Kis vagy feltáró emberi adat.
Related signals
- Multiple Myeloma Clinical Trials & Emerging Therapies
- S2209: Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM)
- Nanomedicine-Empowered CAR‑T Therapy for Multiple Myeloma: Toward Programmable, Durable, and Precision Immunotherapy
- Reaching Consensus on Defining, Treating High‑Risk Myeloma
- Toward a cure for multiple myeloma within a decade